Ozonated Water Inhibits Hepatocellular Carcinoma Invasion and Metastasis by Regulating the HMGB1/NF-κB/STAT3 Signaling Pathway

References

• Ferenci P, Fried M, Labrecque D, et al. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol. 2010;44:239–245.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi:10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Han K, Kim JH. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. World J Gastroenterol. 2015;21:10327–10335. doi:10.3748/wjg.v21.i36.10327
   PubMed Web of Science ®Google Scholar
• Johnson TM, Overgard EB, Cohen AE, DiBaise JK. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943. doi:10.1016/j.jhep.2011.12.001
   PubMed Web of Science ®Google Scholar
• Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017;7:212–219. doi:10.4103/2045-9912.215752
   PubMed Web of Science ®Google Scholar
• Sweet F, Kao MS, Lee SC, Hagar WL, Sweet WE. Ozone selectively inhibits growth of human cancer cells. Science. 1980;209:931–933. doi:10.1126/science.7403859
   PubMed Web of Science ®Google Scholar
• Schulz S, Haussler U, Mandic R, et al. Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. Int J Cancer. 2008;122:2360–2367. doi:10.1002/ijc.23382
   PubMed Web of Science ®Google Scholar
• Teke K, Ozkan TA, Cebeci OO, et al. Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats. Exp Anim. 2017;66:191–198. doi:10.1538/expanim.16-0093
   PubMed Web of Science ®Google Scholar
• Lotfi R, Herzog GI, DeMarco RA, et al. Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells. J Immunol. 2009;183:5023–5031. doi:10.4049/jimmunol.0900504
   PubMed Web of Science ®Google Scholar
• Jiang J, Wang GZ, Wang Y, Huang HZ, Li WT, Qu XD. Hypoxia-induced HMGB1 expression of HCC promotes tumor invasiveness and metastasis via regulating macrophage-derived IL-6. Exp Cell Res. 2018;367:81–88. doi:10.1016/j.yexcr.2018.03.025
   PubMed Web of Science ®Google Scholar
• Venereau E, Casalgrandi M, Schiraldi M, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med. 2012;209:1519–1528. doi:10.1084/jem.20120189
   PubMed Web of Science ®Google Scholar
• Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749–759. doi:10.1038/nri1703
   PubMed Web of Science ®Google Scholar
• Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301–310. doi:10.1038/nrc780
   PubMed Web of Science ®Google Scholar
• Nomura A, Banerjee S, Chugh R, et al. CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer. Oncotarget. 2015;6:8313–8322.
   PubMedGoogle Scholar
• Zhang Y, Zhao Y, Ran Y, Guo J, Cui H, Liu S. Alantolactone exhibits selective antitumor effects in HELA human cervical cancer cells by inhibiting cell migration and invasion, G2/M cell cycle arrest, mitochondrial mediated apoptosis and targeting Nf-kB signalling pathway. J Buon. 2019;24:2310–2315.
   PubMed Web of Science ®Google Scholar
• Song R, Song H, Liang Y, et al. Reciprocal activation between ATPase inhibitory factor 1 and NF-kappaB drives hepatocellular carcinoma angiogenesis and metastasis. Hepatology. 2014;60:1659–1673.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang J, Xu S, et al. Knockdown of PHF5A inhibits migration and invasion of HCC cells via downregulating NF-kappaB Signaling. Biomed Res Int. 2019;2019:1621854. doi:10.1155/2019/1621854
   PubMed Web of Science ®Google Scholar
• Chiang IT, Liu YC, Wang WH, et al. Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-kappaB pathway in hepatocellular carcinoma cells. Vivo. 2012;26:671–681.
   PubMed Web of Science ®Google Scholar
• Hsu FT, Liu YC, Chiang IT, et al. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-kappaB signaling. Int J Oncol. 2014;45:177–188. doi:10.3892/ijo.2014.2423
   PubMed Web of Science ®Google Scholar
• Tsai JJ, Pan PJ, Hsu FT. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-kappaB activation in hepatocellular carcinoma cells. Oncol Rep. 2017;37:1036–1044. doi:10.3892/or.2016.5328
   PubMed Web of Science ®Google Scholar
• Wong VW, Yu J, Cheng AS, et al. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer. 2009;124:2766–2770. doi:10.1002/ijc.24281
   PubMed Web of Science ®Google Scholar
• Zhong Z, Wen Z, Darnell JJ. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264:95–98. doi:10.1126/science.8140422
   PubMed Web of Science ®Google Scholar
• Feng DY, Zheng H, Tan Y, Cheng RX. Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance. World J Gastroenterol. 2001;7:33–36. doi:10.3748/wjg.v7.i1.33
   PubMed Web of Science ®Google Scholar
• Jiang R, Tan Z, Deng L, et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology. 2011;54:900–909. doi:10.1002/hep.24486
   PubMed Web of Science ®Google Scholar
• Calvisi DF, Ladu S, Gorden A, et al. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology. 2006;130:1117–1128. doi:10.1053/j.gastro.2006.01.006
   PubMed Web of Science ®Google Scholar
• Li WC, Ye SL, Sun RX, et al. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res. 2006;12:7140–7148. doi:10.1158/1078-0432.CCR-06-0484
   PubMed Web of Science ®Google Scholar
• Ashizawa Y, Kuboki S, Nojima H, et al. OLFM4 Enhances STAT3 activation and promotes tumor progression by inhibiting GRIM19 expression in human hepatocellular carcinoma. Hepatol Commun. 2019;3:954–970. doi:10.1002/hep4.1361
   PubMed Web of Science ®Google Scholar
• He G, Yu GY, Temkin V, et al. Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell. 2010;17:286–297. doi:10.1016/j.ccr.2009.12.048
   PubMed Web of Science ®Google Scholar
• Meng F, Zhang S, Song R, et al. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-kappaB/miR-188-3p pathways. Ebiomedicine. 2019;44:237–249. doi:10.1016/j.ebiom.2019.05.053
   PubMed Web of Science ®Google Scholar
• Zhang C, Guo F, Xu G, Ma J, Shao F. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Oncol Rep. 20151872;33:1872.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yao J, Wu XP, et al. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway. Mol Carcinog. 2015;54(1):E81–93. doi:10.1002/mc.22182
   PubMedGoogle Scholar
• Bai Y, Lu H, Lin C, et al. Sonic hedgehog-mediated epithelial-mesenchymal transition in renal tubulointerstitial fibrosis. Int J Mol Med. 2016;37:1317–1327. doi:10.3892/ijmm.2016.2546
   PubMed Web of Science ®Google Scholar
• Zheng QM, Lu JJ, Zhao J, Wei X, Wang L, Liu PS. Periostin facilitates the epithelial-mesenchymal transition of endometrial epithelial cells through ILK-akt signaling pathway. Biomed Res Int. 2016;(2016):9842619. doi:10.1155/2016/9842619
   PubMed Web of Science ®Google Scholar
• Redmer T. Deciphering mechanisms of brain metastasis in melanoma - The gist of the matter. Mol Cancer. 2018;17:106. doi:10.1186/s12943-018-0854-5
   PubMed Web of Science ®Google Scholar
• Xiong H, Hong J, Du W, et al. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J Biol Chem. 2012;287:5819–5832. doi:10.1074/jbc.M111.295964
   PubMed Web of Science ®Google Scholar
• Shiau DJ, Kuo WT, Davuluri G, et al. Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis. Sci Rep. 2020;10(1):13582. doi:10.1038/s41598-020-70137-4
   PubMed Web of Science ®Google Scholar